Not all healthcare inequities in diabetes are equal: a comparison of two medically underserved cohorts.


Journal

BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391

Informations de publication

Date de publication:
05 Sep 2024
Historique:
received: 28 03 2024
accepted: 15 08 2024
medline: 7 9 2024
pubmed: 7 9 2024
entrez: 6 9 2024
Statut: epublish

Résumé

Diabetes disparities exist based on socioeconomic status, race, and ethnicity. The aim of this study is to compare two cohorts with diabetes from California and Florida to better elucidate how health outcomes are stratified within underserved communities according to state location, race, and ethnicity. Two cohorts were recruited for comparison from 20 Federally Qualified Health Centers as part of a larger ECHO Diabetes program. Participant-level data included surveys and HbA1c collection. Center-level data included Healthcare Effectiveness Data and Information Set metrics. Demographic characteristics were summarized overall and stratified by state (frequencies, percentages, means (95% CIs)). Generalized linear mixed models were used to compute and compare model-estimated rates and means. Participant-level cohort: 582 adults with diabetes were recruited (33.0% type 1 diabetes (T1D), 67.0% type 2 diabetes (T2D)). Mean age was 51.1 years (95% CI 49.5, 52.6); 80.7% publicly insured or uninsured; 43.7% non-Hispanic white (NHW), 31.6% Hispanic, 7.9% non-Hispanic black (NHB) and 16.8% other. Center-level cohort: 32 796 adults with diabetes were represented (3.4% with T1D, 96.6% with T2D; 72.7% publicly insured or uninsured). Florida had higher rates of uninsured (p<0.0001), lower continuous glucose monitor (CGM) use (18.3% Florida; 35.9% California, p<0.0001), and pump use (10.2% Florida; 26.5% California, p<0.0001), and higher proportions of people with T1D/T2D>9% HbA1c (p<0.001). Risk was stratified within states with NHB participants having higher HbA1c (mean 9.5 (95% CI 8.9, 10.0) compared with NHW with a mean of 8.4 (95% CI 7.8, 9.0), p=0.0058), lower pump use (p=0.0426) and CGM use (p=0.0192). People who prefer to speak English were more likely to use a CGM (p=0.0386). Characteristics of medically underserved communities with diabetes vary by state and by race and ethnicity. Florida's lack of Medicaid expansion could be a factor in worsened risks for vulnerable communities with diabetes.

Identifiants

pubmed: 39242122
pii: 12/4/e004229
doi: 10.1136/bmjdrc-2024-004229
pii:
doi:

Substances chimiques

Glycated Hemoglobin 0
hemoglobin A1c protein, human 0

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Ashby F Walker (AF)

University of Florida Diabetes Institute, Gainesville, Florida, USA afwalker@ufl.edu.
Department of Health Services Research, Management and Policy, University of Florida, Gainesville, Florida, USA.

Michael J Haller (MJ)

University of Florida Diabetes Institute, Gainesville, Florida, USA.
Department of Pediatrics, University of Florida, Gainesville, Florida, USA.

Ananta Addala (A)

Stanford Diabetes Research Center, Stanford, California, USA.
Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.

Stephanie L Filipp (SL)

Department of Pediatrics, University of Florida, Gainesville, Florida, USA.

Rayhan Lal (R)

Division of Endocrinology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

Matthew J Gurka (MJ)

Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.

Lauren E Figg (LE)

Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.

Melanie Hechavarria (M)

Department of Pediatrics, University of Florida, Gainesville, Florida, USA.

Dessi P Zaharieva (DP)

Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.

Keilecia G Malden (KG)

Department of Pediatrics, University of Florida, Gainesville, Florida, USA.

Korey K Hood (KK)

Stanford Diabetes Research Center, Stanford, California, USA.
Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.

Sarah C Westen (SC)

Department of Clinical and Health Psychology, University of Florida, Gainesville, Florida, USA.

Jessie J Wong (JJ)

Stanford Diabetes Research Center, Stanford, California, USA.
Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.

William T Donahoo (WT)

University of Florida Diabetes Institute, Gainesville, Florida, USA.
Division of Endocrinology, Diabetes, & Metabolism, College of Medicine, University of Florida, Gainesville, Florida, USA.
Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA.

Marina Basina (M)

Stanford Diabetes Research Center, Stanford, California, USA.
Division of Endocrinology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

Angelina V Bernier (AV)

Department of Pediatrics, University of Florida, Gainesville, Florida, USA.

Paul Duncan (P)

Department of Health Services Research, Management and Policy, University of Florida, Gainesville, Florida, USA.

David M Maahs (DM)

Stanford Diabetes Research Center, Stanford, California, USA.
Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH